Thymosin β4 reduces IL-17-producing cells and IL-17 expression, and protects lungs from damage in bleomycin-treated mice

Immunobiology

Volumn 219, Issue 6, 2014, Pages 425-431

  Conte, Enrico ^a   Iemmolo, Maria ^a   Fagone, Evelina ^a   Gili, Elisa ^a   Fruciano, Mary ^a   Genovese, Tiziana ^b   Esposito, Emanuela ^b   Cuzzocrea, Salvatore ^b   Vancheri, Carlo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Fibrosis; IL 17; Inflammation; IPF; Lung; Mice; Thymosin 4

Indexed keywords

BLEOMYCIN; COLLAGEN; INTERLEUKIN 17; THYMOSIN BETA4; TRANSFORMING GROWTH FACTOR BETA; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC ANTIBIOTIC; THYMOSIN; THYMOSIN BETA(4);

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFIBROTIC EFFECT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; CHEMISTRY; CYTOLOGY; DISEASE MODEL; INFLAMMATION; LUNG; PATHOLOGY; PULMONARY FIBROSIS; RANDOMIZATION; TOXICITY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; COLLAGEN; DISEASE MODELS, ANIMAL; INFLAMMATION; INTERLEUKIN-17; LEUKOCYTES; LUNG; LUNG INJURY; MALE; MICE; PULMONARY FIBROSIS; RANDOM ALLOCATION; THYMOSIN;

EID: 84899489157     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.02.001     Document Type: Article

References (23)

1. American Thoracic Society/European Respiratory Society American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med. 2002, 165:277-304.
2. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
3. Conte E., Genovese T., Gili E., Esposito E., Iemmolo M., Fruciano M., Fagone E., Pistorio M.P., Crimi N., Cuzzocrea S., Vancheri C. Thymosin beta4 protects C57BL/6 mice from bleomycin-induced damage in the lung. Eur. J. Clin. Invest. 2013, 43:309-315.
4. Conte E., Nigro L., Fagone E., Drago F., Cacopardo B. Quantitative evaluation of interleukin-12 p40 gene expression in peripheral blood mononuclear cells. Immunol. Invest. 2008, 37:143-151.
5. Decraene A., Willems-Widyastuti A., Kasran A., De B.K., Bullens D.M., Dupont L.J. Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable cystic fibrosis patients. Respir. Res. 2010, 11:177.
6. Galuppo M., Esposito E., Mazzon E., Di P.R., Paterniti I., Impellizzeri D., Cuzzocrea S. MEK inhibition suppresses the development of lung fibrosis in the bleomycin model 1. Naunyn-Schmiedeberg's Arch. Pharmacol. 2011, 384:21-37.
7. Girardi M., Sherling M.A., Filler R.B., Shires J., Theodoridis E., Hayday A.C., Tigelaar R.E. Anti-inflammatory effects in the skin of thymosin-beta4 splice-variants. Immunology 2003, 109:1-7.
8. Goldstein A.L., Hannappel E., Kleinman H.K. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol. Med. 2005, 11:421-429.
9. Huff T., Muller C.S., Otto A.M., Netzker R., Hannappel E. beta-Thymosins, small acidic peptides with multiple functions. Int. J. Biochem. Cell Biol. 2001, 33:205-220.
10. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005, 201:233-240.
11. Mi S., Li Z., Yang H.Z., Liu H., Wang J.P., Ma Y.G., Wang X.X., Liu H.Z., Sun W., Hu Z.W. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms. J. Immunol. 2011, 187:3003-3014.
12. Miossec P., Kolls J.K. Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 2012, 11:763-776.
13. Moore B.B., Hogaboam C.M. Murine models of pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 294:L152-L160.
14. Nuovo G.J., Hagood J.S., Magro C.M., Chin N., Kapil R., Davis L., Marsh C.B., Folcik V.A. The distribution of immunomodulatory cells in the lungs of patients with idiopathic pulmonary fibrosis. Mod. Pathol. 2012, 25:416-433.
15. Qiu P., Wheater M.K., Qiu Y., Sosne G. Thymosin beta4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK. FASEB J. 2011, 25:1815-1826.
16. Simonian P.L., Roark C.L., Born W.K., O'Brien R.L., Fontenot A.P. Gammadelta T cells and Th17 cytokines in hypersensitivity pneumonitis and lung fibrosis. Transl. Res. 2009, 154:222-227.
17. Sosne G., Qiu P., Christopherson P.L., Wheater M.K. Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway. Exp. Eye Res. 2007, 84:663-669.
18. Sosne G., Qiu P., Kurpakus-Wheater M. Thymosin beta 4: a novel corneal wound healing and anti-inflammatory agent. Clin. Ophthalmol. 2007, 1:201-207.
19. Sun Y., Yang F., Yan J., Li Q., Wei Z., Feng H., Wang R., Zhang L., Zhang X. New anti-fibrotic mechanisms of n-acetyl-seryl-aspartyl-lysyl-proline in silicon dioxide-induced silicosis. Life Sci. 2010, 87:232-239.
20. Vancheri C., Mastruzzo C., Trovato-Salinaro E., Gili E., Lo F.D., Pistorio M.P., Caruso M., La R.C., Crimi C., Failla M., Crimi N. Interaction between human lung fibroblasts and T-lymphocytes prevents activation of CD4+ cells. Respir. Res. 2005, 6:103.
21. Wilson M.S., Madala S.K., Ramalingam T.R., Gochuico B.R., Rosas I.O., Cheever A.W., Wynn T.A. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J. Exp. Med. 2010, 207:535-552.
22. Xu H., Yang F., Sun Y., Yuan Y., Cheng H., Wei Z., Li S., Cheng T., Brann D., Wang R. A new antifibrotic target of Ac-SDKP: inhibition of myofibroblast differentiation in rat lung with silicosis. PLoS ONE 2012, 7:e40301.
23. Ye P., Garvey P.B., Zhang P., Nelson S., Bagby G., Summer W.R., Schwarzenberger P., Shellito J.E., Kolls J.K. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell. Mol. Biol. 2001, 25:335-340.